NAGLU
N-acetylglucosaminidase, alpha is a protein that in humans is encoded by the NAGLU gene.[3]
Function
This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides.
Clinical significance
Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate.[3]
References
Further reading
- Weber, B.; Blanch, L.; Clements, P. R.; Scott, H. S.; Hopwood, J. J. (1996). "Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B)". Human Molecular Genetics. 5 (6): 771–777. doi:10.1093/hmg/5.6.771. PMID 8776591.
- Clark, A. G.; Glanowski, S.; Nielsen, R.; Thomas, P. D.; Kejariwal, A.; Todd, M. A.; Tanenbaum, D. M.; Civello, D.; Lu, F.; Murphy, B.; Ferriera, S.; Wang, G.; Zheng, X.; White, T. J.; Sninsky, J. J.; Adams, M. D.; Cargill, M. (2003). "Inferring Nonneutral Evolution from Human-Chimp-Mouse Orthologous Gene Trios". Science. 302 (5652): 1960–1963. doi:10.1126/science.1088821. PMID 14671302.
- Yogalingam, G.; Hopwood, J. J. (2001). "Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications". Human Mutation. 18 (4): 264–281. doi:10.1002/humu.1189. PMID 11668611.
- Zhao, H. G.; Li, H. H.; Bach, G.; Schmidtchen, A.; Neufeld, E. F. (1996). "The molecular basis of Sanfilippo syndrome type B". Proceedings of the National Academy of Sciences of the United States of America. 93 (12): 6101–6105. doi:10.1073/pnas.93.12.6101. PMC 39196. PMID 8650226.
- Winder-Rhodes, S. E.; Garcia-Reitböck, P.; Ban, M.; Evans, J. R.; Jacques, T. S.; Kemppinen, A.; Foltynie, T.; Williams-Gray, C. H.; Chinnery, P. F.; Hudson, G.; Burn, D. J.; Allcock, L. M.; Sawcer, S. J.; Barker, R. A.; Spillantini, M. G. (2012). "Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome". Movement Disorders. 27 (2): 312–315. doi:10.1002/mds.24029. PMID 22102531.
- Sasaki, T.; Sukegawa, K.; Masue, M.; Fukuda, S.; Tomatsu, S.; Orii, T. (1991). "Purification and partial characterization of alpha-N-acetylglucosaminidase from human liver". Journal of Biochemistry. 110 (5): 842–846. PMID 1783617.
- Vance, J. M.; Pericak-Vance, M. A.; Elston, R. C.; Conneally, P. M.; Namboodiri, K. K.; Wappner, R. S.; Yu, P. L.; Optiz, J. M. (1980). "Evidence of genetic variation for α-N-acetyl-D-glucosaminidase in black and white populations: A new polymorphism". American Journal of Medical Genetics. 7 (2): 131–140. doi:10.1002/ajmg.1320070207. PMID 6781343.
- Schmidtchen, A.; Greenberg, D.; Zhao, H. G.; Li, H. H.; Huang, Y.; Tieu, P.; Zhao, H. Z.; Cheng, S.; Zhao, Z.; Whitley, C. B.; Di Natale, P.; Neufeld, E. F. (1998). "NAGLU Mutations Underlying Sanfilippo Syndrome Type B". The American Journal of Human Genetics. 62 (1): 64–69. doi:10.1086/301685. PMC 1376809. PMID 9443878.
- Ayala, J. M.; Goyal, S.; Liverton, N. J.; Claremon, D. A.; O'Keefe, S. J.; Hanlon, W. A. (2000). "Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway". Journal of leukocyte biology. 67 (6): 869–875. PMID 10857861.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.